Company news
Kringle Pharma, Inc. news in 2021
Kringle Pharma, Inc.'s news releases, calls and decks from 2021, newest first.
Kringle Pharma Strengthens IP Portfolio with the Formulation Patent in Europe.
December 29, 2021
［Delayed］Financial Results for the Fiscal Year Ended September 30, 2021 (Non-consolidated)
December 16, 2021
Last Patient Out in Phase 2 Study of KP-100IT for the Treatment of ALS
December 8, 2021
Financial Results for the Nine Months Ended June 30, 2021(Non-consolidated)
August 20, 2021